Tougher Import Rules for FDA Imports in 2015 at San Diego, CA

July
 16 - 17 
v
DOUBLETREE BY HILTON HOTEL SAN DIEGO DOWNTOWN, 1646 Front St, San Diego, CA 92101, USA
View Map

Overview:

FDA's and the Customs and Border Patrol Service (CBP) have become increasingly sophisticated and equally demanding in the submission of information and adherence to government procedures. Firm's that fail to understand and properly execute an import and export program find that their shipment is delayed, detained or refused. A number of factors can derail the expectation of a seamless import process. The course covers detailed information about the roles and responsibilities of the various parties involved with an import operation and how to correct the weakest link(s) in the commercial chain. The course will include tips on how to understand FDA's thinking and offer anecdotal examples of FDA's import program curiosities.

Why you should attend:

What happens when your product is detained? FDA will begin a legal process that can become an expensive business debacle. You must respond fully within short timeframes. This is not the time for you to be on a learning curve. You need to have a plan in place and know what you are doing.

The FDA is steadily increasing the legal and prior notice information requirements. If you do not know what those requirements are and you initiate a shipment, your product is figuratively dead in the water. You must be accurate with the import coding information and understand the automated and human review process. If not, you can expect detained shipments. CBP is implemented a new "Automated Commercial Environment" computer program that changes import logistics and information reporting for FDA regulated products. Your shipment may be stopped before it is even loaded at the foreign port.

What happens when FDA decides you should bring the products back to the port of entry after you received a release but you cannot locate the product that has been sold? CBP may fine you three times the value of the shipment. FDA may have other adverse legal concerns and strategies.

When products are refused, you have different options. Some options may cost more than others. For example, your product can be seized and destroyed by the government. You may be fined if you do not act in a timely manner.

These are common problems that become prohibitively expensive. You should know how to avoid common problems or at least how to mitigate the cost by using established and effective business planning.

Who Will Benefit:

·         Domestic importers

·         Foreign exporter

·         Initial importers

·         International trade executives

·         Venture Capitalists

·         Marine insurance underwriters

·         Import Brokers

·         Regulatory affairs managers

·         Import / Export consultants

·         In-house counsel

·         Contract specialists

·         Logistics managers

·         Third party establishment inspection entities

·         Sales managers

·         Investors

Agenda:

Day One:

Lecture 1: FDA Legal Authority Customs and Border Control (CBP) Import Process FDA Import Process Registration and documentation

Lecture 2: FDA Import Process (continued)

Import Brokers

Prior Notice Information

CBP and FDA computer programs

Import Codes

Bonds and Bonded Warehouses

FDA "Notice of Action"

Lecture 3: Import Delays Import Alerts Detention Refusals

Day Two:

Lecture 1: Foreign Inspections FDA 483 - Inspectional Observations

Lecture 2: FDA Warning Letters and Automatic detention

Lecture 3: Import Hypothetical FDA Import for Export Program FDA Export Program Export Hypothetical

Lecture 4: FDA Export Program Special Import Issues

  • Trade Shows
  • Personal Use
  • Compassionate Use

Speaker:

Casper (Cap) Uldriks owns Encore Insight LLC, which provides consulting services on FDA Law. He brings over 32 years of experience from the FDA. He specialized in the FDA's medical device program as a field investigator, served as a senior manager in the Office of Compliance and as an Associate Center Director for the Center for Devices and Radiological Health. He developed enforcement actions and participated in the implementation of new statutory requirements. He is recognized as an exceptional and energetic speaker. His comments are candid, straightforward and of practical value. He understands how FDA thinks, operates and where it is headed.

Location: San Diego, CA        Date: July 16th & 17th, 2015        Time: 9 AM to 5 PM 
Venue: DoubleTree by Hilton Hotel San Diego Downtown

Venue Address: 1646 Front Street, San Diego, California, 92101, USA

Price: $1,295.00   (Seminar for One Delegate)

Register now and save $200. (Early Bird)

Until June 10, Early Bird Price: $1,295.00

From June 11 to July 15, Regular Price: $1,495.00

Contact Information:

NetZealous LLC,

DBA GlobalCompliancePanel

161 Mission Falls Lane,

Suite 216, Fremont, CA 94539, USA         

USA Phone: 800-447-9407

Fax: 302-288-6884

support@globalcompliancepanel.com          

http://www.globalcompliancepanel.com

Event Registration Link - http://bit.ly/1yJGRHn

Speakers


Founder
Encore Insight LLC

Join the conversation

Upcoming events

Clinical Trials and Clinical Product Development in the EU: Regulatory Affairs Aspects

l21 May 15 | 9:00

Overview: The main document from a regulatory perspective in the development...

Q

Seminar on Medical Device Software Development at Boston, MA

l21 May 15 | 9:00

Overview: This seminar is mainly based on the IEC62304:2006 standard and will...

Q

GMP and Regulatory Expectations for Early IND Products

l21 May 15 | 9:00

Overview: This course will present, in one place, the regulations and...

Q

2-day In-person Seminar on Why You Should be worried about HIPAA at SFO, CA

l28 May 15 | 10:00

Overview: We will be discussing the history and evolution of HIPAA...

Q

Human Subjects Research Seminar: Current Regulations under FDA and HIPAA at San Diego, CA

l4 Jun 15 | 9:00

Overview: This two day seminar will provide the foundation for the...

Q

2-day In-person Seminar on Extracting Information from Geochemical Data at Salt Lake City, UT

l4 Jun 15 | 9:00

Overview: Most specialists strongly recommend to sample every meter of the...

Q

Seminar on Quality Assurance for Microbiological Laboratories at Chicago

l4 Jun 15 | 9:00

Overview: QMS is the catch phrase for accreditation and is the backbone of...

Q

2-day In-person Seminar on Using Statistical Methods for ICH Guidelines at Barcelona, Spain

l8 Jun 15 | 9:00

Overview: This hands-on course will provide attendees with an understanding of...

Q

Seminar on International Trade - Strategies to Enhance Financing and Operational Success

l11 Jun 15 | 9:00

Overview: Upon completing this course participants should: ·        ...

Q

Design of Experiments (DOE) for Process Development and Validation at Seattle, WA

l18 Jun 15 | 9:00

Overview: Prior to developing a process control plan as part of an overall...

Q

2-day In-person Seminar on Submitting Marketing Applications in Canada at Seattle, Washington

l18 Jun 15 | 9:00

Overview: Topics included will include the filing of New Drug Submissions for...

Q

Promotion of Biomedical Products: Regulatory Considerations at Baltimore, MD

l25 Jun 15 | 9:00

Overview: This course provides a basic overview of the laws and regulations...

Q

Seminar on How to Conduct Medical Device Risk Analysis Effectively at SFO, CA

l2 Jul 15 | 9:00

Overview: Why companies are prone to having past problems in new devices? One...

Q

Applied Statistics for QA, QC, Manufacturing, and Design Control at SFO, CA

l9 Jul 15 | 9:00

Overview: The 2-day seminar begins with an examination of ISO and FDA...

Q

Design of Experiments (DOE) for Process Development and Validation at Singapore

l9 Jul 15 | 9:00

Overview: Prior to developing a process control plan as part of an overall...

Q

Problem Solving and Root Cause Analysis - the Key to an Effective CAPA System at San Diego, CA

l16 Jul 15 | 9:00

Overview: This program is designed to provide participants...

Q

Seminar on Applied Statistics for Scientists and Engineers at Zurich, Switzerland

l16 Jul 15 | 9:00

Overview Throughout 21 CFR and guidance documents for the pharmaceutical,...

Q

Why You Should be worried about HIPAA at Washington, DC

l23 Jul 15 | 9:00

Overview: We will be discussing the history and evolution of HIPAA...

Q

Statistical Techniques for Medical Device Manufacturers at Philadelphia, PA

l30 Jul 15 | 9:00

Overview: The FDA's Quality System Regulation (QSR) requires device...

Q

The Statistics of- Design Verification, Process Validation, and Statistical Process Control at SFO

l6 Aug 15 | 9:00

Overview: This 2-day seminar provides a 1-day introduction to the statistical...

Q

Seminar on Personal Work Retreat - Refresh, Refocus, and Reactivate at SFO

l6 Aug 15 | 9:00

Overview: With all of the deadlines, projects, and tasks that you have to do...

Q

Construction - Construction Hazards & Basics, for any Jobsite at SFO

l6 Aug 15 | 9:00

Overview: Real world examples of what to expect, and what to prepare for...

Q

Promotion of Biomedical Products: Regulatory Considerations at Los Angeles

l20 Aug 15 | 8:30

Overview: This course provides a basic overview of the laws and regulations...

Q

International Trade: Strategies to Enhance Financing and Operational Success at Los Angeles

l20 Aug 15 | 9:00

Overview: Upon completing this course participants should: ·        ...

Q

Software Risk Analysis Tools for Medical Devices and Risk Mitigation at Chicago

l20 Aug 15 | 9:00

Overview: The FDA recalls related to software performance are on the increase...

Q

ISO/IEC 17025-2005 and Laboratory Accreditation at Boston

l27 Aug 15 | 9:00

Overview: QMS is the catch phrase for accreditation and is the backbone of...

Q

The Job of the Corporate Controller in Today's Environment at SFO

l27 Aug 15 | 9:00

Overview: Prepare yourself to take on the role of the Corporate Controller....

Q